Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries

Abstract

Objective: To determine whether general practitioners (GP) who are readers of independent drug bulletins can be used as an international epidemiological observatory of the criteria adopted by “well informed” doctors in various countries in the management of mild hypertension.

Design: Questionnaire study of GPs' diagnostic criteria for mild hypertension, routine investigation and management of patients with this diagnosis.

Participants: 206 GPs readers of independent drug bulletins in 7 countries, comprising 95 known systematic readers of a local bulletin and 111 randomly selected regular subscribers.

Main outcome measures: Response rate to the questionaire. Diagnostic criteria, routine investigations, and treatment used for patients with mild hypertension.

Results: The study required two months for planning and implementation. Four countries out of eleven had a response rate ≤50% and were excluded; the frequency of responses from other countries was 69%. The average diastolic blood pressure (DBP) considered diagnostic of mild hypertension range from 94 mm Hg (lower threshold) to 106 (upper threshold). A minority (17%) of GPs routinely request the minimum recommended laboratory tests to assess patients. GPs routinely advise non-drug measures before starting a drug. Most would not start drug treatment in patients without other risk factors and a DBP below 100 mmHg. The top first choice drugs were diuretics and β-adrenoceptor blockers. Half of the doctors were able to quote some published guide to the management of mild hypertension, and 18% cited a relevant trial. Attitudes in diagnosing and treating mild hypertension differed widely between GPs and countries.

Conclusions: GP readers of drug bulletins can be used quickly and inexpensively to assess the extent to which recommended diagnostic and therapeutic practices are accepted by “well informed” doctors. The results suggest that attitudes in managing mild hypertension vary widely among GPs and countries and differ remarkably from the recommendations of published guidelines.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bircher J, Bogaert M, Dukes MNG, Eichelbaum M, Gram LF, Huller H, Orme M, Sjoqvist F, Tognoni G (1988) Clinical pharmacology in Europe: An indispensable part of the health service. Eur J Clin Pharmacol 33:535–539

  2. 2.

    Tognoni G, Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Marchioli R, Zussino A (1991) Radomized clinical trials in general practice: lessons from a failure. Bri Med J 303:969–971

  3. 3.

    Herxheimer A (1991) Strategies for improving drug safety in Europe: can general practitioners contribute? In: Kochen MM (ed) Rational pharmacotherpay in practice. Springer, Berlin pp 3–6

  4. 4.

    Editorial (1993) Drug promotion: stealth, wealth, and safety. Lancet 341:1507–1508

  5. 5.

    Grant GB, Gregory DA, van Zwanenberg TD (1985) Development of a limited formulary for general practice. Lancet I:1030–1032

  6. 6.

    Cialdella P, Figon G, Haugh MC, Boissel JP (1991) Prescription intentions in relation to therapeutic information: a study of 117 french general practitioners. Soc Sci Med 33:1263–1274

  7. 7.

    Finer D, Tomson G, eds (1992): Essential drug information. The story of a Workshop. Karolinska Institutet, Stockholm

  8. 8.

    Garattini S, Tognoni G (1993) Drug utilization reviews and pharmacoeconomics. Interaction after parallel development? Pharm Econ 4:162–172

  9. 9.

    Herxheimer A (1987) Basic information that prescribers are not getting about drugs. Lancet I:31–32

  10. 10.

    Herxheimer A (1991) Drug bulletins are part of the scientific literature. Curr Cont Life Sci 34:4–9

  11. 11.

    Guidelines Sub-Committee (1989) 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting. J Hypertens 7:689–693

  12. 12.

    Hodes C, Rogers PA, Everitt MG (1975) High blood pressure: detection and treatment by General Practitioners. Bri Med J 2:674–677

  13. 13.

    Cloher TP, Admin M, Whelton PK (1986) Physician approach to the recognition and initial management of hypertension. Arch Intern Med 146:529–533

  14. 14.

    WHO Drug Utilization Research Group (DURG) (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. Eur J Clin Pharmacol 30:521–525

  15. 15.

    Bucknall CA, Morris GK, Mitchell JRA (1986) Physicians' attitudes to four common problems: hypertension, atrial fibrillation, transient ischaemic attacks, and angina pectoris. Bri Med J 293:739–742

  16. 16.

    Waller PC, Mclnnes GT, Reid JL (1990) Policies for managing hypertensive patients: a survey of the opinions of British specialists. J Hum Hypertens 4:509–515

  17. 17.

    Weiland SK, Keil U, Spelsberg A, Hense KW, Hartel U, Gefeller O, Dieckmann W (1991) Diagnosis and management of hypertension by physicians in the Federal Republic of Germany. J Hypertens 9:131–134

  18. 18.

    Steven ID, Wilson DH, Wakefield MA, Beilby J, Coffey GA, Esterman AJ, Golding AP, Graham NMH, Litt JCB, Rohrsheim RA (1992) South Australian hypertension survey. General practitioner knowledge and reported management practice — a cause for concern? Med J Austr 156:423–428

  19. 19.

    Steven ID, Wilson DH, Wakefield MA, Beilby J, Coffey GA, Esterman AJ, Golding AP, Graham NMH, Litt JCB, Rohrsheim RA (1992) South Australian hypertension survey. General practitioner experiences with drug treatment. Med J Austr 156:641–644

  20. 20.

    Anonymous (1989) Diagnosis and management of hypertension — 1987. A nationwide survey of physicians' knowledge, attitudes and reported behaviour. US Department of Human Sciences. National Institutes of Health

  21. 21.

    Alli C, Avanzini F, Caimi V, Colombo F, Parma E, Passerini G, Tognoni G (1993) General practitioners' approach to the detection and treatment of hypertension. A survey in Lombardy, a region of northern Italy. High Blood Press Cardiovasc Prevent 2:283–290

  22. 22.

    MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–674

  23. 23.

    Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990) Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335:827–838

  24. 24.

    Montanaro N, Magrini N, Vaccheri A, Battilana M (1992) Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989. Eur J Clin Pharmacol 42:401–408

Download references

Author information

Correspondence to G. Tognoni.

Additional information

The organisers in the participating countries were: M. Bogaert, Folia Pharmacotherapeutica (Belgium) · B. Vrhovac, Pharmaca and Bilten O Lijekovima (Croatia) · D. Broclain, La revue Prescrire (France) · P. K. Sarkar, Drug Disease Doctor (India) · P. Hardjasaputra, Farmakon; B. Santoso, S. S. Danu, Lembran Obat dan Pengobatan (Indonesia) · M. Miselli, G. F. Nasi, Informazioni sui Farmaci; D. Coen, Ricerca e Pratica; L. Bozzini, Dialogo sui Farmaci (Italy) · P. K. M. Lunde (Norway) D. Lee, Medicamentos y Terapeutica (Panama) · J. M. Recalde, Boletin terapeutico Andaluz (Spain) · T. N. C. Aturaliya, Drug Information Bulletin (Sri Lanka) · A. Herxheimer, Drug and Therapeutics Bulletin (United Kingdom)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Avanzini, F., Tognoni, G., Colombo, F. et al. How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries. Eur J Clin Pharmacol 49, 445–450 (1996). https://doi.org/10.1007/BF00195929

Download citation

Key words

  • Practioners
  • hypertension
  • general practice
  • disease management
  • international differences